Press releases
Storm Therapuetics today announced that it has raised an additional £4 million of funding from Taiho Ventures, LLC the strategic corporate venture capital arm of Taiho Pharmaceutical Co., Ltd.
Read more
STORM Therapeutics today announced the appointment of both Professor Mark Dawson and Dr Paul Leeson to the Scientific Advisory Board.
Read more
STORM Therapeutics today announced the publication of data in the internationally renowned scientific journal Nature linking an essential RNA-modifying enzyme to acute myeloid leukaemia (AML).
Read more
STORM Therapeutics, the drug discovery company focused on the discovery of small molecule therapies modulating RNA epigenetics, today announced the appointment of Professor Paul Workman to its Board.
Read more
A ceremony at Newmarket Racecourse attracted some of the brightest entrepreneurs in the region.
Read more